These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 18408236)
21. Successful use of intraperitoneal daptomycin in the treatment of vancomycin-resistant enterococcus peritonitis. Huen SC; Hall I; Topal J; Mahnensmith RL; Brewster UC; Abu-Alfa AK Am J Kidney Dis; 2009 Sep; 54(3):538-41. PubMed ID: 19237231 [TBL] [Abstract][Full Text] [Related]
22. Daptomycin for the treatment of vancomycin-resistant enterococcal infections. Grim SA; Hong I; Freeman J; Edwards C; Clark NM J Antimicrob Chemother; 2009 Feb; 63(2):414-6. PubMed ID: 19015143 [No Abstract] [Full Text] [Related]
23. [Emergence of vancomycin-dependent enterococci following glycopeptide therapy: case report and review]. Bert F; Leflon-Guibout V; Le Grand J; Bourdon N; Nicolas-Chanoine MH Pathol Biol (Paris); 2009 Feb; 57(1):56-60. PubMed ID: 18845404 [TBL] [Abstract][Full Text] [Related]
24. Linezolid resistant enterococcus faecium. McNicholas S; Hanahoe B; Higgins F; McAnena O; Corbett-Feeney G; Cormican M Ir Med J; 2008; 101(7):225-6. PubMed ID: 18810787 [No Abstract] [Full Text] [Related]
25. Clonal dissemination of Enterococcus faecalis ST201 and Enterococcus faecium CC17-ST64 containing Tn5382-vanB2 among 16 hospitals in Chile. López M; Hormazábal JC; Maldonado A; Saavedra G; Baquero F; Silva J; Torres C; del Campo R Clin Microbiol Infect; 2009 Jun; 15(6):586-8. PubMed ID: 19392904 [TBL] [Abstract][Full Text] [Related]
27. First report of clinical and epidemiological characterisation of vancomycin-resistant enterococci from mainland China. Cao B; Liu Y; Song S; Li R; Wang H; Wang C Int J Antimicrob Agents; 2008 Sep; 32(3):279-81. PubMed ID: 18614337 [No Abstract] [Full Text] [Related]
28. Colonisation with vancomycin- and linezolid-resistant Enterococcus faecium in a university hospital: molecular epidemiology and risk factor analysis. Souli M; Sakka V; Galani I; Antoniadou A; Galani L; Siafakas N; Zerva L; Fytrou H; Tsiodras S; Giamarellou H Int J Antimicrob Agents; 2009 Feb; 33(2):137-42. PubMed ID: 19013056 [TBL] [Abstract][Full Text] [Related]
29. Identification of a novel genomic island specific to hospital-acquired clonal complex 17 Enterococcus faecium isolates. Heikens E; van Schaik W; Leavis HL; Bonten MJ; Willems RJ Appl Environ Microbiol; 2008 Nov; 74(22):7094-7. PubMed ID: 18836023 [TBL] [Abstract][Full Text] [Related]
30. Evaluation of the quinupristin/dalfopristin breakpoints for Enterococcus faecium. Hammerum AM; Agersø Y; Garcia-Migura L; Mette Seyfarth A; Porsbo LJ; Emborg HD; Bogø Jensen L Int J Antimicrob Agents; 2009 Sep; 34(3):288-90. PubMed ID: 19409762 [No Abstract] [Full Text] [Related]
31. Molecular characterisation of outbreak-related strains of vancomycin-resistant Enterococcus faecium from an intensive care unit in Beijing, China. Zhu X; Zheng B; Wang S; Willems RJ; Xue F; Cao X; Li Y; Bo S; Liu J J Hosp Infect; 2009 Jun; 72(2):147-54. PubMed ID: 19339079 [TBL] [Abstract][Full Text] [Related]
32. Partial teicoplanin dependence in a vancomycin-dependent Enterococcus faecium isolated from an oncology patient 1 month after cessation of teicoplanin therapy, Austria 2007. Huhulescu S; Schmid D; Mayer B; Stadlbauer S; Wewalka G; Allerberger F; Dworzak M Int J Antimicrob Agents; 2008 Jan; 31(1):86-8. PubMed ID: 18006277 [No Abstract] [Full Text] [Related]
33. [Spontaneous bacterial peritonitis produced by Enterococcus faecium]. Ferrero OL; Sánchez LA; Escalada C; Martínez-Odriozola P; Miguel F Enferm Infecc Microbiol Clin; 2000 Apr; 18(4):201. PubMed ID: 10932406 [No Abstract] [Full Text] [Related]